Affiliation:
1. Department of Neurosurgery Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania
Abstract
To determine the plasma baclofen concentrations of children undergoing continuous intrathecal baclofen infusion for treatment of cerebral spasticity, we assayed plasma samples from six children, 8 to 18 years of age, who were receiving intrathecal baclofen at constant rates of 77 to 400 μg/day. Plasma levels were at or below the limit of quantification (10 ng/mL) in all patients. (J Child Neurol 1999;14:408-409).
Subject
Clinical Neurology,Pediatrics, Perinatology, and Child Health
Reference10 articles.
1. Are baclofen-sensitive GABAB receptors present on primary afferent terminals of the spinal cord?
2. (–)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor
3. Plasma and cerebrospinal fluid levels of baclofen (lioresal®) at optimal therapeutic responses in spastic paresis
4. Müller H., Zierski J., Dralle D., et al: Pharmacokinetics of intrathecal baclofen, in Müller H, Zierski J, Penn RD (eds): Local-Spinal Therapy of Spasticity New York , Springer-Verlag, 1988, pp 223-226.
5. Hattab JR: Review of European clinical trials with baclofen, in Feldman RG, Young RRR, Koella WP (eds): Spasticity: Disordered Motor Control. Chicago, Yearbook Medical , 1980, pp 71-85.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献